Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients

10.1093/annonc/mdg118

Saved in:

Bibliographic Details
Main Authors:	Millward, M.J., Boyer, M.J., Lehnert, M., Clarke, S., Rischin, D., Goh, B.-C., Wong, J., McNeil, E., Bishop, J.F.
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	2016
Subjects:	Docetaxel Ethnicity Non-small-cell lung cancer
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/129612
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-129612
record_format	dspace
spelling	sg-nus-scholar.10635-1296122023-10-26T08:51:50Z Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients Millward, M.J. Boyer, M.J. Lehnert, M. Clarke, S. Rischin, D. Goh, B.-C. Wong, J. McNeil, E. Bishop, J.F. PHARMACOLOGY MEDICINE Docetaxel Ethnicity Non-small-cell lung cancer 10.1093/annonc/mdg118 Annals of Oncology 14 3 449-454 ANONE 2016-11-08T08:24:35Z 2016-11-08T08:24:35Z 2003-03-01 Article Millward, M.J., Boyer, M.J., Lehnert, M., Clarke, S., Rischin, D., Goh, B.-C., Wong, J., McNeil, E., Bishop, J.F. (2003-03-01). Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients. Annals of Oncology 14 (3) : 449-454. ScholarBank@NUS Repository. https://doi.org/10.1093/annonc/mdg118 09237534 http://scholarbank.nus.edu.sg/handle/10635/129612 000182406700017 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Docetaxel Ethnicity Non-small-cell lung cancer
spellingShingle	Docetaxel Ethnicity Non-small-cell lung cancer Millward, M.J. Boyer, M.J. Lehnert, M. Clarke, S. Rischin, D. Goh, B.-C. Wong, J. McNeil, E. Bishop, J.F. Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
description	10.1093/annonc/mdg118
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Millward, M.J. Boyer, M.J. Lehnert, M. Clarke, S. Rischin, D. Goh, B.-C. Wong, J. McNeil, E. Bishop, J.F.
format	Article
author	Millward, M.J. Boyer, M.J. Lehnert, M. Clarke, S. Rischin, D. Goh, B.-C. Wong, J. McNeil, E. Bishop, J.F.
author_sort	Millward, M.J.
title	Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
title_short	Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
title_full	Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
title_fullStr	Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
title_full_unstemmed	Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
title_sort	docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase ii study in caucasian and asian patients
publishDate	2016
url	http://scholarbank.nus.edu.sg/handle/10635/129612
_version_	1781790678194323456

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients

Similar Items